Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 5, 2010 - Issue 5
Submit an article Journal homepage
29
Views
2
CrossRef citations to date
0
Altmetric
Drug Profile

Agalsidase alfa for enzyme-replacement therapy in Fabry disease

Atul Mehta Royal Free Hospital and University College Medical School, Pond Street, NW3 2QG, London, UK. [email protected]
Pages 641-652 | Published online: 10 Jan 2014

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Uma Ramaswami. (2011) Update on role of agalsidase alfa in management of Fabry disease. Drug Design, Development and Therapy 5, pages 155-173.
Read now

Articles from other publishers (1)

Guillem Pintos-MorellOlivier LidoveAtul Mehta. (2017) Management of Fabry Disease with Agalsidase Treatment. Clinical Medicine Insights: Therapeutics 2, pages CMT.S6104.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.